Immune checkpoint inhibitors (ICIs) are widely used in the treatment of various tumor types. ICIs kill tumor cells by activating the body's immune function. As this action is nonspecific, it inevitably triggers immune-related adverse events (irAEs), which can... ...

请注册登录后继续浏览